BCL2L1 and neoplasm: Collectively, these results demonstrate that all GBM tested have dual BCL-XL and MCL-1 anti-apoptotic blocks; however, in the face of acute IR treatment, p53 promotes an exclusive dependency on BCL-XL for tumour cell survival.